SCIENTIFIC BACKGROUND

MEFV

Category:

Familial Mediterranean fever (FMF) is the most common familial form of periodic recurrent fever, occurring primarily among people of the southern Mediterranean. The common, classic type of familial Mediterranean fever is inherited in an autosomal recessive manner with reduced penetrance. The condition is particularly common in North Africans, Anatolian Turks, Iraqi Jews, and Armenians. The incidence is 1:2,000 in North Africans, and the heterozygote frequency reaches up to 20% regionally. In 70% of cases the disease starts before the age of 10 years with short-lasting fevers lasting 3-5 days, pleurisy, and peritonitis, accompanied by pain in joints, muscles and abdomen. If left untreated, secondary amyloidosis leads to renal failure and death in 12-40% of cases. Prophylactic administration of colchicine decreases the frequency of relapses and the risk of developing secondary amyloidosis. For FMF patients who do not respond to colchicine, treatment with interleukin-1 blockers appears to be the best therapeutic option.

 

In the classic form of Mediterranean fever, mutations in the marenostrin/pyrin (MEFV) gene on chromosome 16 have been identified, allowing early diagnosis and appropriate treatment. Most cases are caused by a few common mutations (founder effect). However, despite mutation searches in the entire coding region of the MEFV gene, only one mutation is detectable in up to 25% of FMF patients.

 

References

Gattorno et al. 2019, Ann Rheum Dis 78:1025 / Booty et al. 2009, Arhtritis Rheum 60:1851 / Papadopoulos et al. 2008, Annals Hum Genet 72:752 / Giaglis et al. 2007, Clin Genet 71:458 / El-Shanti 2006, Lancet 367:1016 / Majeed et al. 2005, Semin Arhtritis Rheum 34:813 / Lamprecht et al. 2004, Internist 45:904 / Gershoni-Baruch et al. 2001, Eur J Hum Genet 9:634 / Tekin et al. 2000, Clin Genet 57:430 / Dode et al. 2000, Am J Med Genet 92:241

GENES

MEFV
How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more